E. de Miguel

Abstract CT014: Efficacy of intratumoral BO-112 with systemic pembrolizumab in patients with advanced melanoma refractory to anti-PD-1-based therapy: Final results of SPOTLIGHT203 phase 2 study

A. Arance, Helena Escuin-Ordinas, S. Dalle, 2022, Cancer Research.

LB0009 EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update

R. Slart, A. Hočevar, H. Direskeneli, 2023, Annals of the Rheumatic Diseases.